Literature DB >> 23597668

Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.

Chun-Jen Hsueh1, Hung-Wen Kao, Shao-Yuan Chen, Chung-Ping Lo, Chia-Chun Hsu, Dai-Wei Liu, Wen-Lin Hsu.   

Abstract

In 2010, the International Panel on the Diagnosis of Multiple Sclerosis revised the 2005 version of the McDonald criteria. The revisions to MRI dissemination-in-time criteria include adoption of a new criterion by demonstration of simultaneous asymptomatic gadolinium-enhancing and nonenhancing lesions on baseline MRI scans. The purpose of this study was to demonstrate the diagnostic validity of the modified MRI dissemination-in-time criteria. We collected 80 patients with an initial clinical attack suggestive of an acute central nervous system demyelinating disease. The patients were followed for at least two years or until the development of definite multiple sclerosis. The nonconverters were taken as negative cases. Their baseline and follow-up brain MRI studies were retrospectively reviewed by two neuroradiologists. The 2010 version had higher sensitivity (68.2% vs. 45.5%), slightly lower specificity (80.6% vs. 83.3%), and higher accuracy (73.8% vs. 62.5%) than the 2005 version, but the differences were without statistical significance. The new criteria are more sensitive and accurate and specific just as the old criteria. They allow the diagnosis of definite multiple sclerosis in 34.1% patients at first presentation of the clinically isolated syndrome.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597668     DOI: 10.1016/j.jns.2013.03.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.

Authors:  Hanna G Zimmermann; Benjamin Knier; Timm Oberwahrenbrock; Janina Behrens; Catherina Pfuhl; Lilian Aly; Miriam Kaminski; Muna-Miriam Hoshi; Svenja Specovius; René M Giess; Michael Scheel; Mark Mühlau; Judith Bellmann-Strobl; Klemens Ruprecht; Bernhard Hemmer; Thomas Korn; Friedemann Paul; Alexander U Brandt
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

Review 2.  MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Authors:  Massimo Filippi; Maria A Rocca; Olga Ciccarelli; Nicola De Stefano; Nikos Evangelou; Ludwig Kappos; Alex Rovira; Jaume Sastre-Garriga; Mar Tintorè; Jette L Frederiksen; Claudio Gasperini; Jacqueline Palace; Daniel S Reich; Brenda Banwell; Xavier Montalban; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

3.  Applicability of McDonald 2010 and Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) 2016 Magnetic Resonance Imaging Criteria for the Diagnosis of Multiple Sclerosis in Sri Lanka.

Authors:  Sujani Madhurika Kodagoda Gamage; Indunil Wijeweera; Priyangi Wijesinghe; Sanjaya Bandara Adikari; Katharina Fink; Herath Mudiyanselage Ajith Sominanda
Journal:  J Clin Neurol       Date:  2018-05-31       Impact factor: 3.077

Review 4.  Application of the McDonald criteria in Latin America.

Authors:  Liliana Patrucco
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.